“Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction”, Biomed. Res. Ther., vol. 5, no. 12, pp. 2863–2875, Dec. 2018, doi: 10.15419/bmrat.v5i12.505.